Company intelligence / Profile preview

Dartmouth Pharmaceuticals

Hanover, New Hampshire, United States

Ownership: Private
Development stage: Other

Overview

Dartmouth Pharmaceuticals was a biotechnology company focused on the development of small molecule therapeutics targeting the prostaglandin pathway. The company's primary research centered on Prostaglandin E receptor 4 (EP4) antagonists for the treatment of cancer and inflammatory diseases. Founded as a spin-off from Dartmouth College, the company aimed to translate academic research into clinical applications. However, the company is no longer active and appears to have ceased operations several years ago.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Dartmouth Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dartmouth Pharmaceuticals.

Explore the full profile